Bavarian Nordic (OTCMKTS:BVNRY – Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $10.60 and traded as low as $9.66. Bavarian Nordic shares last traded at $9.66, with a volume of 518 shares.
Bavarian Nordic Stock Performance
The company’s 50 day simple moving average is $11.86 and its two-hundred day simple moving average is $10.60. The stock has a market cap of $2.30 billion, a price-to-earnings ratio of 11.10 and a beta of 1.23.
Bavarian Nordic (OTCMKTS:BVNRY – Get Free Report) last released its quarterly earnings data on Friday, August 22nd. The company reported $0.23 earnings per share (EPS) for the quarter. Bavarian Nordic had a return on equity of 12.35% and a net margin of 21.95%.The firm had revenue of $251.14 million during the quarter. On average, equities research analysts predict that Bavarian Nordic will post 0.67 earnings per share for the current fiscal year.
About Bavarian Nordic
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.
See Also
- Five stocks we like better than Bavarian Nordic
- How to Find Undervalued Stocks
- Tesla Has Been Trapped in a 10% Range for Months—What’s Going On?
- What Does Downgrade Mean in Investing?
- dLocal Falls Despite Blowout Q3 Results—What Investors Are Missing
- Compound Interest and Why It Matters When Investing
- Ondas Holdings Signals a Rebound as Drone Demand Soars
Receive News & Ratings for Bavarian Nordic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bavarian Nordic and related companies with MarketBeat.com's FREE daily email newsletter.
